|
Volumn 162, Issue 1, 2001, Pages 61-68
|
Lead treatment in vitro at early developmental stage of bone marrow-derived macrophages enhances NO production through IL-1β and IL-6 but not TNF-α
|
Author keywords
IL 1 ; IL 6; Lead; Macrophages; NO; Proinflammatory cytokines; TNF
|
Indexed keywords
COLONY STIMULATING FACTOR 1;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
LEAD;
NITRIC OXIDE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ANIMAL MODEL;
ARTICLE;
BONE MARROW CELL;
BONE MARROW TOXICITY;
CELL MATURATION;
CELL STRUCTURE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
GENE EXPRESSION;
LEAD POISONING;
MACROPHAGE;
MALE;
MOUSE;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
STEM CELL;
ANIMALS;
BONE MARROW CELLS;
CELL DIFFERENTIATION;
CELL DIVISION;
CYTOKINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
LEAD;
MACROPHAGES;
MALE;
MICE;
MICE, INBRED BALB C;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SPECIFIC PATHOGEN-FREE ORGANISMS;
|
EID: 0035849012
PISSN: 0300483X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0300-483X(01)00354-7 Document Type: Article |
Times cited : (13)
|
References (22)
|